Goldman Sachs Group Inc - Dec 31, 2024 SCHEDULE 13G/A Report for 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (FDMT)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol: FDMT
Shares outstanding: 46.1M shares
Disclosed Ownership: 4.42M shares
Ownership: 9.6%
Form type: SCHEDULE 13G/A
Date filed: 2/10/2025, 05:28 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	9.6%	4.42M	0	4.42M	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	9.6%	4.42M	0	4.42M	Name: Sam Prashanth	Attorney-in-fact